Bill Adolfsen represents a wide range of biotechnology and pharmaceutical companies in intellectual property matters. His experience includes advising companies on all areas of patents, including litigation, post-grant proceedings, licensing, due diligence counseling, and prosecution. Bill has particular experience litigating pharmaceutical cases under the Hatch-Waxman Act. Through his extensive work in the biotechnology industry as a scientist and business development manager, Bill has broad experience in commercializing life science technologies such as small molecule drugs, therapeutic antibodies, recombinant proteins, synthetic genes, biobased industrial chemicals, and biofuels.
As an experienced molecular biologist, Bill’s technical experience covers a number of scientific fields including biochemistry, molecular biology, stem cells, antibodies, immunology, genetics, neuroscience, synthetic biology, genome engineering, and bioenergy. His doctoral research at MIT focused on the molecular mechanisms underlying synaptic transmission. Results from his work have appeared in several journals, including the Journal of Cell Biology, PNAS, Neuron, and Science.
- Codon Devices, Cambridge, MA, Business Development Associate, 2008 - 2009
- Wisconsin Alumni Research Foundation, Madison, WI, Manager, 2007 - 2008
- HHMI/University of Wisconsin, Madison, WI, Postdoctoral Fellow, 2006 - 2007
- Codon Devices, Cambridge, MA, Scientist, 2005
- Merck Research Laboratories, Rahway, NJ, Summer Intern in Immunology, 1999
- Rutgers University, Department of Biochemistry, New Brunswick, NJ, Researcher, 1998 - 1999
- University of Wisconsin Law School, J.D., 2013
- Massachusetts Institute of Technology, Ph.D., Molecular Biology, 2005
- Rutgers, The State University of New Jersey, B.S., Biotechnology, 1999